Cargando…

Immunotherapy in Breast Cancer: When, How, and What Challenges?

Breast Cancer (BC) is the second most frequent cause of cancer death among women worldwide and, although there have been significant advances in BC therapies, a significant percentage of patients develop metastasis and disease recurrence. Since BC was demonstrated to be an immunogenic tumor, immunot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henriques, Beatriz, Mendes, Fernando, Martins, Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616011/ https://www.ncbi.nlm.nih.gov/pubmed/34829916 http://dx.doi.org/10.3390/biomedicines9111687

Ejemplares similares

Immunotherapy in Head and Neck Cancer When, How, and Why?
por: Pereira, Daniela, et al.
Publicado: (2022)

Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?
por: Deligne, Claire, et al.
Publicado: (2022)

Treatment in advanced colorectal cancer: what, when and how?
por: Chau, I, et al.
Publicado: (2009)

What’s next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination
por: Redwood, Alec J., et al.
Publicado: (2022)

What? When? And How?
por: Hutchinson, Jonathan
Publicado: (1890)

Immunotherapy: A Challenge of Breast Cancer Treatment
por: García-Aranda, Marilina, et al.
Publicado: (2019)

Citrate: How to Get Started and What, When, and How to Monitor?
por: Honore, Patrick M., et al.
Publicado: (2018)

Immunotherapy in myeloma: Why, when and how?
por: van de Donk, Niels W.C.J.
Publicado: (2018)

Fungal Genomics in Respiratory Medicine: What, How and When?
por: Brackin, Amelie P., et al.
Publicado: (2021)

Immunotherapy: Review of the Existing Evidence and Challenges in Breast Cancer
por: Hu, Yun, et al.
Publicado: (2023)

Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
por: Mediratta, Karan, et al.
Publicado: (2020)

Surveillance in testicular cancer: who, when, what and how?
por: Sohaib, S.A., et al.
Publicado: (2007)

Outcomes and quality of life following breast cancer treatment in older women: When, why, how much, and what do women want?
por: Mandelblatt, Jeanne, et al.
Publicado: (2003)

Germline TP53 Testing in Breast Cancers: Why, When and How?
por: Evans, D. Gareth, et al.
Publicado: (2020)

What, When and How to Measure—Peripheral Biomarkers in Therapy of Huntington’s Disease
por: Przybyl, Lukasz, et al.
Publicado: (2021)

The When, What & How of Measuring Vitamin D Metabolism in Clinical Medicine
por: Dirks, Niek F., et al.
Publicado: (2018)

Chimeric antigen receptor T-cell immunotherapy in breast cancer: development and challenges
por: Toulouie, Sara, et al.
Publicado: (2021)

The role of immunotherapy in advanced renal cell carcinoma
por: Mondlane, Ercília Rita, et al.
Publicado: (2021)

What to Eat, and What to Drink, and How, and When, and Where to Do It
por: Pratt, B. H.
Publicado: (1869)

External validation of prognostic models: what, why, how, when and where?
por: Ramspek, Chava L, et al.
Publicado: (2020)

Iron supplementation in the intensive care unit: when, how much, and by what route?
por: Lapointe, Marc
Publicado: (2004)

Plasticity within the αβ(+)CD4(+) T-cell lineage: when, how and what for?
por: Coomes, Stephanie M., et al.
Publicado: (2013)

Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy
por: Yang, Ruoning, et al.
Publicado: (2022)

Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges
por: Wang, Xiaoxiao, et al.
Publicado: (2023)

Breast Cancer Resistance Mechanisms: Challenges to Immunotherapy
por: Hanna, Ann, et al.
Publicado: (2021)

What Is Recent in Pancreatic Cancer Immunotherapy?
por: Niccolai, Elena, et al.
Publicado: (2013)

Immune Monitoring upon Treatment with Biologics in Sjögren’s Syndrome: The What, Where, When, and How
por: van Beers, Joyce J.B.C., et al.
Publicado: (2021)

Palliative care in intensive care units: why, where, what, who, when, how
por: Mercadante, Sebastiano, et al.
Publicado: (2018)

Joint aspiration for diagnosis of chronic periprosthetic joint infection: when, how, and what tests?
por: Quinlan, Nicole Durig, et al.
Publicado: (2023)

Future Challenges in Cancer Resistance to Immunotherapy
por: van Elsas, Marit J., et al.
Publicado: (2020)

Recent Advances and Challenges in Cancer Immunotherapy
por: Peterson, Chelsea, et al.
Publicado: (2022)

The Role of Words in Cognitive Tasks: What, When, and How?
por: Robinson, Christopher W., et al.
Publicado: (2012)

Treatment strategies in axial spondyloarthritis: what, when and how?
por: Fragoulis, George E, et al.
Publicado: (2020)

Imaging for Plasma Cell Dyscrasias: What, When, and How?
por: Guha, Amrita, et al.
Publicado: (2022)

Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion
por: Gumber, Diana, et al.
Publicado: (2022)

Immunotherapy in breast cancer
por: Bayraktar, Soley, et al.
Publicado: (2019)

Breast cancer resistance to chemotherapy: When should we suspect it and how can we prevent it?
por: Prihantono, et al.
Publicado: (2021)

Colorectal Cancer Screening—Who, How, and When?
por: Bevan, Roisin, et al.
Publicado: (2018)

Cancer-associated thrombosis: the when, how and why
por: Fernandes, Caio J., et al.
Publicado: (2019)

Radiotherapy in Pancreatic Cancer: To Whom, When, and How?
por: Falco, Michał, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ea2pgp28u54dd7akc1r6kfofj2